Breast Disease Research Center, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu, 610041, Sichuan, People's Republic of China.
Department of Breast Surgery, Sichuan Academy of Medical Sciences, Sichuan Province People's Hospital, Chengdu, 610072, Sichuan, People's Republic of China.
Aesthetic Plast Surg. 2023 Dec;47(6):2221-2231. doi: 10.1007/s00266-023-03285-3. Epub 2023 Feb 23.
Reduction mammoplasty (RM) is an important procedure in the management of symptomatic greater breast hypertrophy with or without early-stage breast cancer. We aim to introduce a new procedure: the three-pedicle reduction mammaplasty technique.
A prospectively maintained database was reviewed, and two prospectively registered clinical studies were included of all breast hypertrophy patients with or without breast cancer who underwent three-pedicle RM with inverted T incision at West China Hospital or the Fourth People's Hospital of Sichuan Province from 2018 to 2022. Patient demographics, patient-reported cosmetic results, quality of life (QoL), surgical outcomes and complications were assessed.
During a median period of 22.5 months, 101 reduction mammaplasties were performed (M= 35.80; M= 27.05). Mean reduction weight was 880.9 g ranging from 423-1630 g per breast. The nipple-to-sternal notch distance (N-SN) at post-operation was significantly shorter than preoperatively (left, 34.51 cm; right, 34.69 cm). Major complications and minor complications were 1.9% (1/52 patients) and 13.5% (7/52 patients), respectively. Multivariate logistic regression analyses showed that BMI > 30 was independent risk factors for a complication. Except for sexual and physical well-being at 1-month post-operation, patients gave a higher score on the BREAST-Q (breast satisfaction, physical well-being, psychosocial well-being) after the operation than before the operation (P<0.001).
The three-pedicle RM technique was demonstrated to be an effective and safe RM procedure for moderate to severe breast hypertrophy patients with or without breast cancer, with the advantages of removing the lesions, reducing hypertrophic breasts and accomplishing mammoplasty.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors http://www.springer.com/00266.
缩乳术（RM）是治疗有症状的大乳房肥大症（伴或不伴早期乳腺癌）的重要手段。我们旨在介绍一种新的手术方法：三蒂 RM 技术。
回顾前瞻性维护的数据库，并纳入 2018 年至 2022 年期间在华西医院或四川省第四人民医院接受三蒂 RM 术（倒 T 切口）的所有伴或不伴乳腺癌的乳房肥大症患者的前瞻性注册的两项临床研究。评估患者的人口统计学数据、患者报告的美容效果、生活质量（QoL）、手术结果和并发症。
在中位 22.5 个月期间，共进行了 101 例 RM 手术（M=35.80；M=27.05）。平均减少的重量为 880.9g，每侧乳房为 423-1630g。术后乳头到胸骨切迹的距离（N-SN）明显短于术前（左侧 34.51cm；右侧 34.69cm）。主要并发症和次要并发症分别为 1.9%（52 例患者中有 1 例）和 13.5%（52 例患者中有 7 例）。多变量逻辑回归分析表明，BMI>30 是发生并发症的独立危险因素。除术后 1 个月的性和身体幸福感外，患者在手术后的 BREAST-Q（乳房满意度、身体幸福感、心理幸福感）评分均高于手术前（P<0.001）。
三蒂 RM 技术是一种有效且安全的 RM 手术，适用于伴或不伴乳腺癌的中重度乳房肥大症患者，具有切除病变、减少肥大乳房和完成乳房整形的优点。
证据等级 IV：本杂志要求作者为每篇文章分配一个证据等级。有关这些循证医学评级的完整描述，请参考目录或在线作者指南。http://www.springer.com/00266。
